HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yunjian Li Selected Research

Therapeutics

12/2023Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages.
1/2022Nanodiamond-based multifunctional platform for oral chemo-photothermal combinational therapy of orthotopic colon cancer.
1/2020Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy.
11/2019Synthesis, Formulation, and Characterization of Doxorubicin-Loaded Laponite/Oligomeric Hyaluronic Acid-Aminophenylboronic Acid Nanohybrids and Cytological Evaluation against MCF-7 Breast Cancer Cells.
8/2019The utilization of low molecular weight heparin-poloxamer associated Laponite nanoplatform for safe and efficient tumor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yunjian Li Research Topics

Disease

7Neoplasms (Cancer)
12/2023 - 08/2019
2Leukemia
12/2023 - 12/2023
2Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 10/2021
2Wounds and Injuries (Trauma)
08/2021 - 10/2010
1Breakthrough Infections
12/2023
1Bites and Stings (Sting)
12/2023
1Infections
12/2023
1Colonic Neoplasms (Colon Cancer)
01/2022
1Necrosis
06/2021
1Fibrosis (Cirrhosis)
12/2019
1Infarction (Infarctions)
12/2019
1Breast Neoplasms (Breast Cancer)
11/2019
1Hepatocellular Carcinoma (Hepatoma)
03/2019

Drug/Important Bio-Agent (IBA)

4S63845IBA
12/2023 - 10/2021
3Proteins (Proteins, Gene)FDA Link
07/2022 - 10/2010
3CurcuminIBA
01/2022 - 07/2021
3Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2020
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 01/2020
2PolymersIBA
07/2021 - 01/2020
2MicellesIBA
06/2021 - 01/2020
2Hyaluronic Acid (Hyaluronan)IBA
01/2020 - 11/2019
2laponiteIBA
11/2019 - 08/2019
1VaccinesIBA
12/2023
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
12/2023
1GSK690693IBA
12/2023
1navitoclaxIBA
12/2023
1MK 2206IBA
12/2023
1CaspasesIBA
12/2023
1Broadly Neutralizing AntibodiesIBA
12/2023
1AntibodiesIBA
12/2023
1Mitochondrial DNA (mtDNA)IBA
12/2023
1Estrogen ReceptorsIBA
07/2022
1Progesterone Receptors (Progesterone Receptor)IBA
07/2022
1Epidermal Growth Factor (EGF)IBA
07/2022
1polydopamineIBA
01/2022
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2022
1ChitosanIBA
01/2022
1NanodiamondsIBA
01/2022
1AlginatesIBA
07/2021
1GelatinIBA
07/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021
1alpha-TocopherolFDA Link
01/2020
1Messenger RNA (mRNA)IBA
12/2019
1MicroRNAs (MicroRNA)IBA
12/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2019
13-aminobenzeneboronic acidIBA
11/2019
1Poloxamer (Poloxamer 407)IBA
08/2019
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2019
1B7-H1 AntigenIBA
03/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2010
1N-acetyltalosaminuronic acid (NAT)IBA
10/2010

Therapy/Procedure

5Therapeutics
12/2023 - 08/2019
3Drug Therapy (Chemotherapy)
01/2022 - 01/2020
1Induced Hyperthermia (Thermotherapy)
06/2021
1Phototherapy (Light Therapy)
06/2021
1Lasers (Laser)
06/2021
1Combined Modality Therapy
06/2021
1Immunotherapy
03/2019